Is there still a room for improvement in antimicrobial use in a setting where use of broad-spectrum antibiotics require approval of an infectious diseases physician?

Infect Control Hosp Epidemiol. 2022 Jun;43(6):802-804. doi: 10.1017/ice.2022.81. Epub 2022 Apr 11.

Authors

Gökhan Metan^{1

2}, Ömrüm Uzun², Gülçin Telli Dizman^{1

2}, Meliha Çağla Sönmezer², Ahmet Çağkan İnkaya², Gülşen Hazırolan³, Murat Akova², Serhat Ünal^{1

2}

Affiliations

¹ Infection Control Committee Hacettepe University Hospitals, Ankara, Turkey.
² Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
³ Department of Medical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

PMID: 35403590
DOI: 10.1017/ice.2022.81

No abstract available

MeSH terms

Anti-Bacterial Agents / therapeutic use
Anti-Infective Agents*
Communicable Diseases* / drug therapy
Humans
Physicians*

Substances

Anti-Bacterial Agents
Anti-Infective Agents